HIGH GRADE GLIOMA
Clinical trials for HIGH GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE GLIOMA trials appear
Sign up with your email to follow new studies for HIGH GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental immune therapy targets deadly childhood brain cancers
Disease control TerminatedThis early-phase study tested whether a custom-made vaccine and special immune cells (T-cells) could be given safely to children with newly diagnosed high-grade gliomas, a very aggressive brain cancer. The treatment used the patient's own tumor to create a vaccine that would trai…
Matched conditions: HIGH GRADE GLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated May 26, 2026 06:12 UTC
-
Promising brain cancer strategy falls short: trial ends early
Disease control TerminatedThis study tested giving chemotherapy and radiation before surgery for people with a newly diagnosed, removable glioblastoma (a fast-growing brain cancer). The goal was to see if this approach could improve tumor control and survival. Only 2 people enrolled before the trial was s…
Matched conditions: HIGH GRADE GLIOMA
Phase: PHASE2 • Sponsor: Geisinger Clinic • Aim: Disease control
Last updated May 26, 2026 06:05 UTC
-
Sound waves and Light-Activated drug tested against aggressive brain tumors
Disease control TerminatedThis early-phase study tested a new approach called sonodynamic therapy for people with recurrent high-grade glioma, a fast-growing brain tumor. Participants received a drug called ALA followed by focused ultrasound to activate it. The goal was to check safety and see if the trea…
Matched conditions: HIGH GRADE GLIOMA
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New drug delivery method for brain tumors tested in small study
Knowledge-focused TerminatedThis early-stage trial enrolled 5 people with recurrent high-grade glioma (a type of aggressive brain tumor). Participants received a single dose of the drug temsirolimus, given directly into the brain's blood vessels or through a vein, on the same day as planned tumor removal su…
Matched conditions: HIGH GRADE GLIOMA
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC